Related Experiment Video

Updated: Jun 28, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.4K

Immune Response and Metastasis-Links between the Metastasis Driver MACC1 and Cancer Immune Escape Strategies

Sebastian Torke1, Wolfgang Walther1, Ulrike Stein1

  • 1Experimental and Clinical Research Center, Charité, Medical Centre Berlin and Max-Delbrück-Center for Molecular Medicine, 13125 Berlin, Germany.

Cancers
|April 13, 2024
PubMed

Insights

Metastasis-associated in colon cancer 1 (MACC1) protein is a key driver of cancer metastasis and immune evasion. Understanding MACC1’s role in immune escape is crucial for developing new cancer therapies targeting metastasis.

Area of Science:

  • Oncology
  • Cancer Biology
  • Immunology

Background:

  • Metastasis is a primary cause of cancer-related mortality and a significant challenge in cancer therapy.
  • Metastasis-associated in colon cancer 1 (MACC1) is a validated biomarker across numerous cancer types, linked to several cancer hallmarks.
  • The role of MACC1 in facilitating immune evasion, a critical aspect of cancer progression, is not well understood.

Purpose of the Study:

  • To review the direct and indirect connections between MACC1 and cancer immune escape mechanisms.
  • To elucidate how MACC1 influences signaling pathways and secreted factors involved in immune evasion.
  • To explore the impact of MACC1 on immune cell infiltration and anti-tumor activity.

Main Methods:

  • Literature review focusing on MACC1 and cancer immunology.
  • Analysis of signaling pathways regulated by MACC1.
  • Investigation of MACC1-influenced secreted factors affecting the tumor microenvironment.

Main Results:

  • MACC1 is implicated in multiple mechanisms of immune evasion in various cancers.
  • MACC1 modulates key signaling pathways that contribute to suppressing anti-tumor immunity.
  • MACC1 influences the secretion of factors that impair immune cell function and infiltration.

Conclusions:

  • MACC1 plays a significant role in promoting cancer immune evasion.
  • Targeting MACC1 may offer a novel therapeutic strategy to overcome immune escape in metastatic cancers.
  • Further research into MACC1-mediated immune modulation is essential for advancing cancer treatment.
Keywords:
MACC1immune evasionmetastasis

More Related Videos

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

19.5K
The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

9.3K

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K